Repare Therapeutics Inc
NASDAQ:RPTX
Income Statement
Earnings Waterfall
Repare Therapeutics Inc
Revenue
|
51.1m
USD
|
Operating Expenses
|
-167.4m
USD
|
Operating Income
|
-116.2m
USD
|
Other Expenses
|
22.4m
USD
|
Net Income
|
-93.8m
USD
|
Income Statement
Repare Therapeutics Inc
Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
+200%
|
1
+100%
|
1
+50%
|
8
+744%
|
8
+4%
|
8
+5%
|
121
+1 352%
|
132
+9%
|
137
+4%
|
167
+22%
|
56
-66%
|
51
-9%
|
|
Operating Income | ||||||||||||||||||
Operating Expenses |
(26)
|
(32)
|
(39)
|
(47)
|
(54)
|
(65)
|
(80)
|
(98)
|
(116)
|
(130)
|
(142)
|
(149)
|
(152)
|
(157)
|
(160)
|
(161)
|
(167)
|
|
Selling, General & Administrative |
(5)
|
(7)
|
(9)
|
(12)
|
(13)
|
(17)
|
(20)
|
(22)
|
(26)
|
(30)
|
(31)
|
(32)
|
(32)
|
(32)
|
(33)
|
(33)
|
(34)
|
|
Research & Development |
(21)
|
(26)
|
(30)
|
(35)
|
(39)
|
(48)
|
(59)
|
(75)
|
(89)
|
(100)
|
(111)
|
(117)
|
(117)
|
(124)
|
(127)
|
(128)
|
(132)
|
|
Depreciation & Amortization |
(1)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
(2)
|
|
Operating Income |
(26)
N/A
|
(32)
-23%
|
(39)
-21%
|
(47)
-19%
|
(54)
-15%
|
(65)
-22%
|
(80)
-22%
|
(97)
-22%
|
(109)
-12%
|
(122)
-12%
|
(134)
-10%
|
(29)
+78%
|
(20)
+31%
|
(20)
+1%
|
7
N/A
|
(105)
N/A
|
(116)
-11%
|
|
Pre-Tax Income | ||||||||||||||||||
Interest Income Expense |
(1)
|
(2)
|
(1)
|
(0)
|
(0)
|
1
|
1
|
0
|
0
|
0
|
1
|
3
|
6
|
9
|
12
|
13
|
13
|
|
Non-Reccuring Items |
0
|
0
|
0
|
1
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
|
Pre-Tax Income |
(27)
N/A
|
(35)
-29%
|
(40)
-16%
|
(46)
-15%
|
(55)
-19%
|
(64)
-16%
|
(79)
-24%
|
(97)
-23%
|
(109)
-12%
|
(122)
-12%
|
(133)
-9%
|
(26)
+80%
|
(14)
+47%
|
(11)
+24%
|
19
N/A
|
(92)
N/A
|
(103)
-12%
|
|
Net Income | ||||||||||||||||||
Tax Provision |
(0)
|
(0)
|
(0)
|
(0)
|
1
|
2
|
2
|
3
|
2
|
2
|
1
|
0
|
(15)
|
(19)
|
(22)
|
(5)
|
9
|
|
Income from Continuing Operations |
(27)
|
(35)
|
(40)
|
(47)
|
(53)
|
(62)
|
(77)
|
(94)
|
(107)
|
(120)
|
(132)
|
(26)
|
(29)
|
(29)
|
(3)
|
(97)
|
(94)
|
|
Net Income (Common) |
(27)
N/A
|
(35)
-29%
|
(40)
-15%
|
(47)
-15%
|
(53)
-15%
|
(62)
-17%
|
(77)
-23%
|
(94)
-22%
|
(107)
-14%
|
(120)
-13%
|
(132)
-10%
|
(26)
+81%
|
(29)
-13%
|
(29)
-1%
|
(3)
+90%
|
(97)
-3 147%
|
(94)
+4%
|
|
EPS (Diluted) |
-0.78
N/A
|
-1
-28%
|
-1.09
-9%
|
-1.26
-16%
|
-1.45
-15%
|
-1.68
-16%
|
-2.07
-23%
|
-2.53
-22%
|
-2.83
-12%
|
-2.87
-1%
|
-3.15
-10%
|
-0.58
+82%
|
-0.69
-19%
|
-0.69
N/A
|
-0.07
+90%
|
-2.31
-3 200%
|
-2.23
+3%
|